Castle Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $85,782 | $87,002 | $72,974 | $66,120 |
Gross Profit | 70,173 | 69,772 | 56,395 | 51,026 |
EBITDA | 12,024 | 11,504 | 865 | 685 |
EBIT | 8,483 | 8,156 | -2,475 | -2,539 |
Net Income | 2,269 | 8,920 | -2,534 | -2,580 |
Net Change In Cash | 85,782 | 87,002 | 72,974 | 66,120 |
Free Cash Flow | 16,960 | 18,769 | -15,987 | 20,285 |
Cash | 94,959 | 85,572 | 82,949 | 98,841 |
Basic Shares | 29,401 | 28,738 | 27,485 | 27,030 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $219,788 | $137,039 | $94,085 | $62,649 |
Gross Profit | 174,806 | 105,030 | 78,263 | 52,964 |
EBITDA | -45,024 | -58,344 | -36,605 | -7,094 |
EBIT | -57,354 | -68,887 | -40,012 | -7,566 |
Net Income | -57,466 | -67,138 | -31,292 | -10,284 |
Net Change In Cash | 219,788 | 137,039 | 94,085 | 62,649 |
Free Cash Flow | -19,247 | -47,287 | -22,466 | 5,114 |
Cash | 98,841 | 122,948 | 329,633 | 409,852 |
Basic Shares | 26,802 | 26,054 | 25,137 | 18,929 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.08 |
2024-06-30 | $0.31 |
2024-03-31 | -$0.09 |
2023-12-31 | -$0.10 |
